Sign Up Today and Learn More About Verily Stock
Invest in or calculate the value of your shares in Verily or other pre-IPO companies through EquityZen's platform.

Verily Stock
Verily develops tools and devices to collect, organize and activate health data.
About Verily Stock
Founded
2015
Headquarters
San Francisco, CA, US
Total Funding
1.8B
Industries
Software, Artificial Intelligence, Data and Analytics
Verily aspires to create a world in which technology and life sciences are not distinct, but partners with a united mission. Formerly Google Life Sciences, Verily's mission is to bring together technology and life sciences to uncover new truths about health and disease. Verily's multidisciplinary teams have access to advanced research tools, large-scale computing power, and unique technical expertise. They work with partners from across the industry and many fields of research to develop new technology, launch studies, and start companies.
Verily Press Mentions
Stay in the know about the latest news on Verily
DFW deals: KKR may buy Nothing Bundt Cakes for $2 billion-plus
bizjournals • Mar 26, 2026
AI in drug discovery and development: news watch
pharmaphorum • Mar 26, 2026
Dallas-Based Verily Raises $300M, Ending Alphabet’s Controlling Stake
dallasinnovates • Mar 26, 2026
NYSE Content Update: Michael + Susan Dell to Ring Opening Bell with Invest America
prnewswire • Mar 25, 2026
NYSE Content Update: Michael + Susan Dell to Ring Opening Bell with Invest America
en • Mar 25, 2026
Verily Management
Leadership team at Verily
Head of Engineering
Linus Upson
CEO
Andy Conrad

Join now and verify your accreditation status to gain access to:
- Verily Current Valuation
- Verily Stock Price
- Verily Management
- Available deals in Verily and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Verily Cap Table and Funding History by Share Class and Liquidity Preferences
- Verily Revenue and Financials
- Verily Highlights
- Verily Business Model
- Verily Risk Factors
- Verily Research Report from SACRA Research
Trading Verily Stock
How to invest in Verily stock?
Accredited investors can buy pre-IPO stock in companies like Verily through EquityZen funds. These investments are made available by existing Verily shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Verily stock?
Shareholders can sell their Verily stock through EquityZen's private company marketplace. EquityZen's network includes over 440K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 52K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."




